220 related articles for article (PubMed ID: 24119290)
61. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
[TBL] [Abstract][Full Text] [Related]
62. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate.
Peters HP; Laarakkers CM; Swinkels DW; Wetzels JF
Nephrol Dial Transplant; 2010 Mar; 25(3):848-53. PubMed ID: 19854845
[TBL] [Abstract][Full Text] [Related]
63. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
[TBL] [Abstract][Full Text] [Related]
64. Is there association between uric acid and inflammation in hemodialysis patients?
Lobo JC; Stockler-Pinto MB; da Nóbrega AC; Carraro-Eduardo JC; Mafra D
Ren Fail; 2013; 35(3):361-6. PubMed ID: 23394103
[TBL] [Abstract][Full Text] [Related]
65. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
66. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
67. Serum Hepcidin Levels in Multiple Myeloma.
Victor M; Evgeniy H; Gergana T; Julia P; Vasil V; Borislav M; Ivo B; Zlatina G; Kamen T
Clin Lab; 2017 Jul; 63(7):1273-1277. PubMed ID: 28792693
[TBL] [Abstract][Full Text] [Related]
68. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
[TBL] [Abstract][Full Text] [Related]
69. Association between hepcidin, haemoglobin level and iron status in stage 4 chronic kidney disease patients with anaemia.
Mogadam RA; Nemati A; Amani F; Ghorbanihaghjo A; Argani H; Bashardoust B
J Pak Med Assoc; 2015 Apr; 65(4):354-7. PubMed ID: 25976565
[TBL] [Abstract][Full Text] [Related]
70. Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.
Rangel-López A; Paniagua-Medina ME; Urbán-Reyes M; Cortes-Arredondo M; Alvarez-Aguilar C; López-Meza J; Ochoa-Zarzosa A; Lindholm B; García-López E; Paniagua JR
Mutagenesis; 2013 Mar; 28(2):219-25. PubMed ID: 23408844
[TBL] [Abstract][Full Text] [Related]
71. Hepcidin, iron status, and inflammation variables among healthy pregnant women in the Turkish population.
Simavli S; Derbent AU; Uysal S; Turhan NÖ
J Matern Fetal Neonatal Med; 2014 Jan; 27(1):75-9. PubMed ID: 23662610
[TBL] [Abstract][Full Text] [Related]
72. Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis.
Kuragano T; Itoh K; Shimonaka Y; Kida A; Furuta M; Kitamura R; Yahiro M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
Nephrol Dial Transplant; 2011 Aug; 26(8):2663-7. PubMed ID: 21245128
[TBL] [Abstract][Full Text] [Related]
73. Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness.
Yong K; Ooi EM; Dogra G; Mannion M; Boudville N; Chan D; Lim EM; Lim WH
Cytokine; 2013 Oct; 64(1):39-42. PubMed ID: 23778029
[TBL] [Abstract][Full Text] [Related]
74. Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modality.
Rastmanesh MM; Braam B; Joles JA; Boer P; Bluyssen HA
Eur J Pharmacol; 2009 Jan; 602(1):163-7. PubMed ID: 19041303
[TBL] [Abstract][Full Text] [Related]
75. Elevated Plasma Cyclophillin A in Hemodialysis and Peritoneal Dialysis Patients: a Novel Link to Systemic Inflammation.
Jin K; Vaziri ND
Iran J Kidney Dis; 2017 Jan; 11(1):44-49. PubMed ID: 28174352
[TBL] [Abstract][Full Text] [Related]
76. Serum hepcidin predicts uremic accelerated atherosclerosis in chronic hemodialysis patients with diabetic nephropathy.
Li H; Feng SJ; Su LL; Wang W; Zhang XD; Wang SX
Chin Med J (Engl); 2015 May; 128(10):1351-7. PubMed ID: 25963357
[TBL] [Abstract][Full Text] [Related]
77. Hepcidin is a key mediator of anemia of inflammation in Crohn's disease.
Basseri RJ; Nemeth E; Vassilaki ME; Basseri B; Enayati P; Shaye O; Bourikas LA; Ganz T; Papadakis KA
J Crohns Colitis; 2013 Sep; 7(8):e286-91. PubMed ID: 23219355
[TBL] [Abstract][Full Text] [Related]
78. The removal of serum hepcidin by different dialysis membranes.
Kuragano T; Furuta M; Shimonaka Y; Kida A; Yahiro M; Otaki Y; Hasuike Y; Matsumoto A; Nakanishi T
Int J Artif Organs; 2013 Oct; 36(9):633-9. PubMed ID: 23918276
[TBL] [Abstract][Full Text] [Related]
79. Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients.
Ford BA; Eby CS; Scott MG; Coyne DW
Kidney Int; 2010 Oct; 78(8):769-73. PubMed ID: 20668427
[TBL] [Abstract][Full Text] [Related]
80. Relation of serum hepcidin levels and restless legs syndrome in chronic hemodialysis patients.
Tufekci A; Kara E
Sleep Breath; 2021 Jun; 25(2):897-905. PubMed ID: 33029690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]